|| Home || || Contact || Free Research Publications || Eshop || Privacy Statement ||
Transactivation Lines in Rice
Evaluation of insertional mutants and development of effective transactivator platform for FTO and co-ordinate gene expression by Marie Connett Porceddu, Thach Tran, Richard Jefferson and Andrzej Kilian, CAMBIA.
August 2006
RIRDC Publication No 06/095 RIRDC Project No CMB-2A
At the end of the project,
these concerns have both been addressed. A patent work-around was developed,
a strategy to co-transform or cross the vector containing the open reading
frame for the transcriptional activator, and the vector containing the
DNA-binding activation site, so that the insertions would be unlinked.
In patent claims over the use of promoters, often what is claimed is a
construct that comprises the promoter “operably linked” to a gene of interest.
In transactivation, the promoter of interest is not linked to a gene of
interest, but to a transcriptional activator. We also constructed a set
of new transactivator cassettes, through identification of an activation
domain and a DNA binding domain that work better in plants and are less
clearly dominated by IP rights.
Lines that express this transactivator in a defined pattern are determined by the enhancers or promoters near the site of insertion. Genes that it is desired to switch on can be placed into cassettes with a minimal promoter and an activation sequence for the transactivator. When these cassettes are transformed into plants containing or crossed with the pattern lines, the gene(s) of interest will be brought into the expression pattern shown by the reporter genes in a highly controlled useful manner without the need to define, analyse, and clone new promoters to drive the gene(s) of interest. Thus:
“Freedom to co-operate”
considerations are equally important with “Freedom to operate” and technical
evaluation. The new transactivator is now available to the rice industry,
but even more useful, it is presented as a capability to use it, together
with the accumulated know-how, in a form that enables ready collaboration
with other researchers and capture of the data they collect and the improvements
they make, in the BioForge project (www.bioforge.net)
being developed since 2005 by CAMBIA with US-sourced funding from the Rockefeller
Foundation. Facilitating joint improvement and leverage, all technology
presented on the BioForge is available to other researchers in the public
and private sectors only if they agree to the collaborative terms of the
BiOS license (www.bioslicense.net).
This unique legal instrument developed by CAMBIA provides for norms of sharing, as well as legally binding covenants that protect those who have invested in a technology, such as RIRDC, from being subject to the situation of inability to use valuable improvements to the technology.
A summary of the BiOS License conditions follows: In return for the benefits of the technologies, a licensee institution agrees to allow and encourage its employees and students to post on the website any improvements made to the technologies and safety information relevant to use of the technology and potential regulatory approval of products embodying it, and agrees not to assert any intellectual property rights to the improvements and information against other licensees.
![]()
|